Heparin-induced thrombocytopenia

Suitable for clinicians and hematology consultants, this title includes: coverage of approved and novel pharmacotherapies, dosing guidelines, and the advantages and limitations of alternative anticoagulants; review of the immune basis and pathogenesis, animal models, and laboratory testing for HIT a...

Descripción completa

Detalles Bibliográficos
Otros Autores: Warkentin, Theodore E., 1960- editor (editor), Greinacher, Andreas, editor
Formato: Libro electrónico
Idioma:Inglés
Publicado: Boca Raton, Florida ; London ; New York : CRC Press [2013]
Edición:Fifth edition
Colección:Fundamental and clinical cardiology series (unnumbered)
Materias:
Acceso en línea:https://recursos.uloyola.es/login?url=https://accedys.uloyola.es:8443/accedix0/sitios/ebook.php?id=143778
Ver en Universidad Loyola - Universidad Loyola Granada:https://colectivo.uloyola.es/Record/ELB143778
Solicitar por préstamo interbibliotecario: Correo
Descripción
Sumario:Suitable for clinicians and hematology consultants, this title includes: coverage of approved and novel pharmacotherapies, dosing guidelines, and the advantages and limitations of alternative anticoagulants; review of the immune basis and pathogenesis, animal models, and laboratory testing for HIT antibodies; and more.
Descripción Física:1 online resource (xi, 641 pages) : illustrations
ISBN:9781841848617